Morpho (MORPHO) is currently priced at $1.19, showing a 24-hour increase of 4.64%. The price fluctuated between a low of $1.11 and a high of $1.21 over the same period, indicating a relatively tight daily range of 0.1%.

The trading volume stands at approximately 14.03 million, resulting in a volume-to-market cap ratio of 2.16%, suggesting moderate trading activity. The hourly moving averages indicate short-term resistance at $1.20, as both the 8 SMA and 13 SMA are slightly below this level, while the 21 SMA and 55 SMA are indicating a slight bullish trend.

The 1-hour Relative Strength Index (RSI) is at 52, suggesting that the asset is currently in a neutral position, neither overbought nor oversold. In contrast, the 7-day RSI of 42 indicates potential bearish momentum, as it approaches the oversold territory, reflecting a 7-day price decline of approximately 16.11%.

Morpho's price performance over the past 14 days is nearly flat, with a minor decline of 0.75%, while it has shown a slight positive change of 0.44% over the past 30 days. The asset's all-time high of $4.17, reached in January 2025, underscores significant long-term upside potential if market conditions improve.

Given the current data, the short-term indicators show potential resistance around $1.20, and the declining 7-day RSI suggests caution. However, the recent price bounce could indicate a short-term recovery, warranting closer observation.

Overall, I recommend a Hold rating on Morpho (MORPHO) for the near term. While there are signs of a potential short-term recovery, the bearish momentum over the past week and the resistance at $1.20 suggest that investors should wait for clearer bullish signals before entering new positions.